These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 28440796)
1. The importance of international collaboration for rare diseases research: a European perspective. Julkowska D; Austin CP; Cutillo CM; Gancberg D; Hager C; Halftermeyer J; Jonker AH; Lau LPL; Norstedt I; Rath A; Schuster R; Simelyte E; van Weely S Gene Ther; 2017 Sep; 24(9):562-571. PubMed ID: 28440796 [TBL] [Abstract][Full Text] [Related]
2. A Global Approach to Rare Diseases Research and Orphan Products Development: The International Rare Diseases Research Consortium (IRDiRC). Cutillo CM; Austin CP; Groft SC Adv Exp Med Biol; 2017; 1031():349-369. PubMed ID: 29214582 [TBL] [Abstract][Full Text] [Related]
3. The European union policy in the field of rare diseases. Montserrat Moliner A; Waligóra J Public Health Genomics; 2013; 16(6):268-77. PubMed ID: 24503587 [TBL] [Abstract][Full Text] [Related]
4. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders. Parker S Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190 [TBL] [Abstract][Full Text] [Related]
5. [France in the European and International research landscape]. Julkowska D Med Sci (Paris); 2018 May; 34 Hors série n°1():55-57. PubMed ID: 29911567 [No Abstract] [Full Text] [Related]
6. Policies and actions to tackle rare diseases at European level. Montserrat A; Taruscio D Ann Ist Super Sanita; 2019; 55(3):296-304. PubMed ID: 31553326 [TBL] [Abstract][Full Text] [Related]
7. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis. Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524 [TBL] [Abstract][Full Text] [Related]
8. Consensus document on European brain research. Olesen J; Baker MG; Freund T; di Luca M; Mendlewicz J; Ragan I; Westphal M J Neurol Neurosurg Psychiatry; 2006 Aug; 77 Suppl 1(Suppl 1):i1-49. PubMed ID: 16845120 [TBL] [Abstract][Full Text] [Related]
9. The European Union Policy in the Field of Rare Diseases. Moliner AM; Waligora J Adv Exp Med Biol; 2017; 1031():561-587. PubMed ID: 29214592 [TBL] [Abstract][Full Text] [Related]
10. The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact. Lochmüller H; Torrent I Farnell J; Le Cam Y; Jonker AH; Lau LP; Baynam G; Kaufmann P; Dawkins HJ; Lasko P; Austin CP; Boycott KM; Eur J Hum Genet; 2017 Dec; 25(12):1293-1302. PubMed ID: 29158551 [TBL] [Abstract][Full Text] [Related]
11. New and evolving rare diseases research programs at the National Institutes of Health. Groft SC; Rubinstein YR Public Health Genomics; 2013; 16(6):259-67. PubMed ID: 24503586 [TBL] [Abstract][Full Text] [Related]
12. Undiagnosed Diseases: Italy-US Collaboration and International Efforts to Tackle Rare and Common Diseases Lacking a Diagnosis. Taruscio D; Floridia G; Salvatore M; Groft SC; Gahl WA Adv Exp Med Biol; 2017; 1031():25-38. PubMed ID: 29214564 [TBL] [Abstract][Full Text] [Related]
13. Towards government-funded special biomedical research programs to combat rare diseases in China. Chen K; Yao L; Liu Z Biosci Trends; 2015 Apr; 9(2):88-90. PubMed ID: 25902953 [TBL] [Abstract][Full Text] [Related]
14. Rare-disease project has global ambitions. Abbott A Nature; 2011 Apr; 472(7341):17. PubMed ID: 21475168 [No Abstract] [Full Text] [Related]
15. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data. Groft SC; Posada de la Paz M Adv Exp Med Biol; 2017; 1031():3-21. PubMed ID: 29214563 [TBL] [Abstract][Full Text] [Related]
16. EU Pancreas: an integrated European platform for pancreas cancer research--from basic science to clinical and public health interventions for a rare disease. Milne R; La Vecchia C; Van Steen K; Hahn S; Buchholz M; Costello E; Esposito I; Hoheisel JD; Lange B; Lopez-Bigas N; Michalski CW; Real FX; Brand A; Malats N Public Health Genomics; 2013; 16(6):305-12. PubMed ID: 24503591 [TBL] [Abstract][Full Text] [Related]
17. 'IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases. Lochmüller H; Le Cam Y; Jonker AH; Lau LP; Baynam G; Kaufmann P; Lasko P; Dawkins HJ; Austin CP; Boycott KM Eur J Hum Genet; 2017 Feb; 25(2):162-165. PubMed ID: 27782107 [TBL] [Abstract][Full Text] [Related]
18. Towards the international interoperability of clinical research networks for rare diseases: recommendations from the IRDiRC Task Force. Nabbout R; Zanello G; Baker D; Black L; Brambilla I; Buske OJ; Conklin LS; Davies EH; Julkowska D; Kim Y; Klopstock T; Nakamura H; Nielsen KG; Pariser AR; Pastor JC; Scarpa M; Smith M; Taruscio D; Groft S Orphanet J Rare Dis; 2023 May; 18(1):109. PubMed ID: 37161573 [TBL] [Abstract][Full Text] [Related]
19. Future of Rare Diseases Research 2017-2027: An IRDiRC Perspective. Austin CP; Cutillo CM; Lau LPL; Jonker AH; Rath A; Julkowska D; Thomson D; Terry SF; de Montleau B; Ardigò D; Hivert V; Boycott KM; Baynam G; Kaufmann P; Taruscio D; Lochmüller H; Suematsu M; Incerti C; Draghia-Akli R; Norstedt I; Wang L; Dawkins HJS; Clin Transl Sci; 2018 Jan; 11(1):21-27. PubMed ID: 28796445 [No Abstract] [Full Text] [Related]
20. Rare Disease Biospecimens and Patient Registries: Interoperability for Research Promotion, a European Example: EuroBioBank and SpainRDR-BioNER. Rubinstein YR; Posada de la Paz M; Mora M Adv Exp Med Biol; 2017; 1031():141-147. PubMed ID: 29214569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]